UCB (OTCMKTS:UCBJY) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

UCB SA (OTCMKTS:UCBJY) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $95.59 and traded as low as $81.63. UCB shares last traded at $81.73, with a volume of 39,804 shares.

UCB Stock Performance

The business’s 50 day simple moving average is $96.07 and its two-hundred day simple moving average is $95.59. The company has a quick ratio of 0.78, a current ratio of 1.19 and a debt-to-equity ratio of 0.33.

UCB Company Profile

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.